These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26921751)

  • 41. B7 costimulation and intracellular indoleamine-2,3-dioxygenase expression in peripheral blood of healthy pregnant and pre-eclamptic women.
    Toldi G; Vásárhelyi B; Biró E; Fügedi G; Rigó J; Molvarec A
    Am J Reprod Immunol; 2013 Mar; 69(3):264-71. PubMed ID: 23289444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High levels of IDO-expressing CD16+ peripheral cells, and Tregs in graft biopsies from kidney transplant recipients under belatacept treatment.
    Furuzawa-Carballeda J; Lima G; Uribe-Uribe N; Avila-Casado C; Mancilla E; Morales-Buenrostro LE; Pérez-Garrido J; Pérez M; Cárdenas G; Llorente L; Alberú J
    Transplant Proc; 2010 Nov; 42(9):3489-96. PubMed ID: 21094802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Priming of peripheral monocytes with prolactin (PRL) sensitizes IFN-gamma-mediated indoleamine 2,3-dioxygenase (IDO) expression without affecting IFN-gamma signaling.
    Kawaguchi R; Shimokawa T; Umehara N; Nunomura S; Tanaka T; Ra C
    J Reprod Immunol; 2008 Apr; 77(2):117-25. PubMed ID: 17942160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential immunosuppressive function of plasma indoleamine 2,3-dioxygenase in patients with aGVHD after allo-HSCT.
    Zhao XS; Liu KY; Liu DH; Xu LP; Chen H; Huang XJ
    Clin Transplant; 2011; 25(3):E304-11. PubMed ID: 21355883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.
    Muller AJ; Sharma MD; Chandler PR; Duhadaway JB; Everhart ME; Johnson BA; Kahler DJ; Pihkala J; Soler AP; Munn DH; Prendergast GC; Mellor AL
    Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17073-8. PubMed ID: 18952840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality.
    Pertovaara M; Raitala A; Lehtimäki T; Karhunen PJ; Oja SS; Jylhä M; Hervonen A; Hurme M
    Mech Ageing Dev; 2006 May; 127(5):497-9. PubMed ID: 16513157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Indoleamine-dioxygenase is expressed in human decidua at the time maternal tolerance is established.
    von Rango U; Krusche CA; Beier HM; Classen-Linke I
    J Reprod Immunol; 2007 Jun; 74(1-2):34-45. PubMed ID: 17321596
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human epidermal langerhans cells express the immunoregulatory enzyme indoleamine 2,3-dioxygenase.
    von Bubnoff D; Bausinger H; Matz H; Koch S; Häcker G; Takikawa O; Bieber T; Hanau D; de la Salle H
    J Invest Dermatol; 2004 Aug; 123(2):298-304. PubMed ID: 15245429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alpha-galactosylceramide modulates the induction of indoleamine 2,3-dioxygenase in antigen presenting cells.
    Fallarini S; Paoletti T; Panza L; Lombardi G
    Biochem Pharmacol; 2008 Sep; 76(6):738-50. PubMed ID: 18671950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Indoleamine 2,3-dioxygenase in transplantation.
    Mulley WR; Nikolic-Paterson DJ
    Nephrology (Carlton); 2008 Jun; 13(3):204-11. PubMed ID: 18221253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Indoleamine 2,3-dioxygenase (IDO) is involved in promoting the development of anterior chamber-associated immune deviation.
    Chen X; Liu L; Yang P; Wu C; Jin H; Xing L; Li B; Zhou H; Huang X; Zhu L
    Immunol Lett; 2006 Nov; 107(2):140-7. PubMed ID: 17055065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IDO expressing dendritic cells suppress allograft rejection of small bowel transplantation in mice by expansion of Foxp3+ regulatory T cells.
    Xie FT; Cao JS; Zhao J; Yu Y; Qi F; Dai XC
    Transpl Immunol; 2015 Oct; 33(2):69-77. PubMed ID: 26002283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional study.
    Furuzawa-Carballeda J; Lima G; Jakez-Ocampo J; Llorente L
    Eur J Clin Invest; 2011 Oct; 41(10):1037-46. PubMed ID: 21366559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD11b(+) cells in donor-specific transfusion prolonged allogenic skin graft survival through indoleamine 2,3-dioxygenase.
    Ikemoto T; Takita M; Levy MF; Shimada M; Naziruddin B
    Cell Immunol; 2013; 283(1-2):81-90. PubMed ID: 23933136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice.
    Szántó S; Koreny T; Mikecz K; Glant TT; Szekanecz Z; Varga J
    Arthritis Res Ther; 2007; 9(3):R50. PubMed ID: 17511858
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical relevance of indoleamine 2,3-dioxygenase for alloimmunity and transplantation.
    Brandacher G; Margreiter R; Fuchs D
    Curr Opin Organ Transplant; 2008 Feb; 13(1):10-5. PubMed ID: 18660700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients.
    Speeckaert R; Vermaelen K; van Geel N; Autier P; Lambert J; Haspeslagh M; van Gele M; Thielemans K; Neyns B; Roche N; Verbeke N; Deron P; Speeckaert M; Brochez L
    Eur J Cancer; 2012 Sep; 48(13):2004-11. PubMed ID: 22033321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tryptophan catabolism and T cell responses.
    Mellor AL; Munn D; Chandler P; Keskin D; Johnson T; Marshall B; Jhaver K; Baban B
    Adv Exp Med Biol; 2003; 527():27-35. PubMed ID: 15206713
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The indoleamine 2,3-dioxygenase inhibitor 1-methyl-tryptophan suppresses mitochondrial function, induces aerobic glycolysis and decreases interleukin-10 production in human lymphocytes.
    Eleftheriadis T; Pissas G; Karioti A; Antoniadi G; Liakopoulos V; Dafopoulou K; Pournaras S; Koukoulis G; Stefanidis I
    Immunol Invest; 2012; 41(5):507-20. PubMed ID: 22594922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple myeloma cell-derived IL-32γ increases the immunosuppressive function of macrophages by promoting indoleamine 2,3-dioxygenase (IDO) expression.
    Yan H; Dong M; Liu X; Shen Q; He D; Huang X; Zhang E; Lin X; Chen Q; Guo X; Chen J; Zheng G; Wang G; He J; Yi Q; Cai Z
    Cancer Lett; 2019 Apr; 446():38-48. PubMed ID: 30660652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.